Fatty Liver Disease Clinical Trial
— fattyliverOfficial title:
Prevelance of Non Alcoholic Fatty Liver Disease,Its Complications Among Employees at Banha University Hospital,Egypt
Verified date | July 2020 |
Source | Benha University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This was cross sectional study at Banha University Hospital among employees. Age of the subjects from 20-60 years old both males and females .All investigations done plus abdominal ultrasound for grading of fatty liver and dopler for carotid intima media thickness.
Status | Completed |
Enrollment | 165 |
Est. completion date | August 25, 2019 |
Est. primary completion date | February 20, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 60 Years |
Eligibility |
Inclusion Criteria: All subjects was appear healthy with and without DM or hypertension ,also obese or non - Exclusion Criteria: Any chronic liver disease , Hepatitis C virus patients (HCV) , Hepatitis B virus patients(HBV) and autoimmune liver disease - |
Country | Name | City | State |
---|---|---|---|
Egypt | Benha University | Banha |
Lead Sponsor | Collaborator |
---|---|
Benha University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Atherosclerosis among fatty liver employees at Banha University | Measure the carotid intima media thickness if more than 6mm it will considered atherosclerosis | 15 month | |
Other | The associated 7 risk factors | Age>45 years old,DM ,Hypertension ,Urban area,GGT ,ALP and BMI>30kg/m2 | 15 month | |
Primary | prevalence of fatty liver among employees at Banha University | Grades of fatty liver was measured as 1,2,3 according to the relation of echogencity beween liver and Right kidney | 15 month | |
Secondary | fatty pancreas among employees at Banha University as compication for fatty liver | Fatty Pancreas was measured by grades 1,2,3 according to the echogencity of retroperitoneal fatt as well as left kidney and liver echogencity | 15 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05881005 -
NAC- NAFLD And Cushing
|
N/A | |
Recruiting |
NCT05220956 -
Impact of Time-restricted Feeding in NAFLD
|
N/A | |
Enrolling by invitation |
NCT04066608 -
Prevalence of Advanced Fibrosis in Patients Living With HIV
|
||
Recruiting |
NCT04302051 -
Assessment of Fatty Liver With Thermo-acoustic Device
|
||
Recruiting |
NCT04496895 -
The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults
|
N/A | |
Recruiting |
NCT05880316 -
Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting
|
N/A | |
Active, not recruiting |
NCT05898841 -
Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load
|
Phase 4 | |
Completed |
NCT05764811 -
SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity
|
N/A | |
Active, not recruiting |
NCT05076058 -
Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver
|
N/A | |
Recruiting |
NCT05421572 -
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
|
||
Recruiting |
NCT06302049 -
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
|
Phase 1/Phase 2 | |
Completed |
NCT04283942 -
Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism
|
N/A | |
Completed |
NCT01016418 -
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT04175392 -
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04191044 -
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
|
||
Not yet recruiting |
NCT06071923 -
Effect of Thyroid Disorders in Liver Diseases
|
||
Recruiting |
NCT04525833 -
Liver Disease and Other Systemic Diseases
|
||
Not yet recruiting |
NCT05966025 -
Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
|
Phase 2 | |
Completed |
NCT04844450 -
A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795
|
Phase 1 | |
Completed |
NCT05694923 -
Effect of Sodium Glucose Cotransporter Inhibitors on Non Diabetic Fatty Liver Disease Patients
|
N/A |